Table 3 Clinical features of 65 cases reported
Case | First author | Age (years) | Surgical procedure | Tumor diameter (cm) | Pathological features | Adjuvant therapy | Follow-up (months) | |||
|---|---|---|---|---|---|---|---|---|---|---|
Necrosis | Hemorrhage | Mitosis (≥ 2 per 10 HPF) | Nuclear atypia (grade II/III) | |||||||
1 | Haroon [14] | 3 | LSO | 7 | - | - | - | - | - | No recurrence (25) |
2 | Yoshimatsu [15] | 4 | RSO | 8 | + | + | + (3) | - | BEP×3 | No recurrence (7) |
3 | Qian [16] | 5 | RSO | 8 | - | - | - | - | - | No recurrence (60) |
4 | Gupta [17] | 5 | Tumor resection | NA | NA | NA | NA | NA | - | No recurrence (4) |
5 | Sawathiparnich [18] | 6 | LSO | 7 | + | - | + (2–5) | - | - | No recurrence (6) |
6 | Lee [19] | 8 | RO | 5 | - | - | - | - | - | No recurrence (16) |
7 | Bas [7] | 9 | HE, BSO | 2.5 | - | - | - | - | Glucocorticoid | No recurrence (52) |
8 | Yilmaz [5] | 13 | Tumor resection | 2.5 | - | - | - | - | - | No recurrence (6) |
9 | Schnuckle [20] | 14 | LSO | 3.2 | - | + | - | - | - | No recurrence (24) |
10 | Yokozawa [6] | 16 | Tumor resection | 4 | - | - | - | - | - | No recurrence (15) |
11 | Yuan [21] | 17 | Tumor resection | 8 | - | - | - | - | - | No recurrence (6) |
12 | Sielert [22] | 20 | RO | 5.5 | - | - | - | - | - | No recurrence (18) |
13 | Jiang [23] | 21 | HE, BSO, OE | L 20, R 15 | + | + | + (>10) | + | PVB×4 | Continued and died (10) |
14 | Santo [24] | 21 | RSO | 11.5 | - | + | + (4) | - | - | No recurrence (43) |
15 | Zhang [25] | 21 | LSO, OE | 5.8 | - | - | - | - | - | No recurrence (3) |
16 | Matsukawa [26] | 22 | Tumor resection | 3 | - | - | - | - | - | No recurrence (60) |
17 | Arora [27] | 22 | HE, LSO | 2 | NA | NA | NA | NA | - | Recurred (108) |
18 | Jiang [23] | 23 | Tumor resection | 6 | - | - | - | - | - | No recurrence (36) |
19 | Wong [28] | 24 | RSO | 4.5 | - | - | - | - | - | No recurrence (9) |
20 | Haroon [14] | 26 | RSO | 4.5 | - | - | - | - | - | No recurrence (15) |
21 | Menghua [29] | 28 | LO | 2.5 | + | NA | Active cell growth | NA | - | Recurred (42), died (58) |
22 | Swain [30] | 28 | LSO | 5.9 | NA | NA | NA | NA | - | No recurrence (12) |
23 | Haroon [14] | 28 | HE, BSO | 3 & 2.5 | - | - | + (2) | - | - | No recurrence (49) |
24 | Li [31] | 29 | RSO | 6 | + | + | + | + | Docetaxel + Ne-daplatin ×8 | Recurred (18), died (24) |
25 | Tai [8] | 29 | RSO | 10 | - | + | - | - | - | No recurrence (24) |
26 | Alves [4] | 30 | Tumor resection | 2 | - | - | - | - | - | No recurrence (36) |
27 | Liu [32] | 30 | Tumor resection | 3 | - | - | - | - | - | No recurrence (12) |
28 | Haroon [14] | 32 | HE, BSO | 4 | - | - | - | - | - | No recurrence (71) |
29 | Chung [33] | 35 | HE, BSO, PLND, OE, AE | 4.9 | - | - | - | - | GnRHa ×6 | No recurrence (43) |
30 | Stephens [34] | 35 | RSO | 5 | NA | NA | - | NA | - | No recurrence (6) |
31 | Faten [9] | 36 | RO | 4.5 | - | - | - | - | - | No recurrence (12) |
32 | Haroon [14] | 37 | LSO | 7 | - | - | - | - | - | No recurrence (23) |
33 | Ben [35] | 39 | LSO | 3.4 | NA | NA | NA | NA | - | No recurrence (8) |
34 | Chen [36] | 40 | RSO | 6 | NA | NA | NA | NA | - | No recurrence (36) |
35 | Varras [37] | 40 | HE, BSO | 6.8 | - | - | - | - | - | No recurrence (18) |
36 | Haroon [14] | 43 | RSO | 10 | - | - | + (5) | + | - | Recurred (34) |
37 | Zang [38] | 46 | LSO | 12 | NA | NA | NA | - | - | No recurrence (12) |
38 | Kim [39] | 46 | HE, BSO, PLND, OE | 7.7 | NA | NA | NA | NA | - | Recurred (60) |
39 | Reedy [40] | 46 | HE, LSO, PLNS, OE | 3.6 | - | - | - | - | - | No recurrence (12) |
40 | Lee [41] | 47 | HE, BSO, OE | 11 | - | + | + (5) | + | BEP ×3 | No recurrence (24) |
41 | Wang [42] | 48 | HE, RSO, PLND, OE | 4 | - | - | - | + | - | No recurrence (6) |
42 | Nakasone [43] | 50 | HE, BSO, PLNS | 9 | - | - | NA | - | - | Recurred (70) |
43 | Haroon [14] | 50 | RSO | 7 | - | - | - | - | - | No recurrence (11) |
44 | Haroon [14] | 51 | HE, BSO, PLND, OE | 13 | + | + | + (8) | + | - | Recurred and died (8) |
45 | Chun [44] | 52 | LSO | 6 | - | - | + (5) | - | - | No recurrence (21) |
46 | Kim [45] | 52 | BSO, PLNS, OE | 7.5 | - | - | - | - | - | No recurrence (24) |
47 | Haroon [14] | 52 | LSO | 9 | - | - | + (4) | + | PVB ×4 & radioth-erapy | No recurrence (43) |
48 | Cooray [46] | 54 | HE, BSO | L 3, R 4 | - | - | - | - | - | No recurrence (12) |
49 | Faraj [47] | 55 | BO | 4.5 | NA | NA | NA | NA | - | No recurrence (12) |
50 | Layla [48] | 65 | BSO, TD | 7 | - | NA | + (2) | - | BEP ×6 | Continued (18) |
51 | Brewer [49] | 58 | HE, BSO, TD | 10 | NA | NA | + (9) | + | BEP ×2, GnRHa | Recurred (28) |
52 | Sedhom [50] | 67 | HE, BSO, TD | 9.8 | NA | + | + (22) | NA | - | Died after operation |
53 | Stephens [51] | 67 | HE, BSO | 1.2 | - | - | - | - | - | No recurrence (3) |
54 | Haroon [14] | 67 | BSO | 3.4 | - | - | - | - | - | No recurrence (27) |
55 | Singh [52] | 70 | RO | 5 | NA | NA | NA | NA | - | No recurrence (5) |
56 | Powell [53] | 93 | HE, BSO, sigmoid-ectomy, colostomy | 21 | + | NA | + | + | - | Recurred and multi metastasis (10) |